Cargando…

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis

Detalles Bibliográficos
Autores principales: Kim, Jieun, Seki, Ekihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040959/
https://www.ncbi.nlm.nih.gov/pubmed/36681094
http://dx.doi.org/10.1016/j.jcmgh.2022.12.018
_version_ 1784912599137124352
author Kim, Jieun
Seki, Ekihiro
author_facet Kim, Jieun
Seki, Ekihiro
author_sort Kim, Jieun
collection PubMed
description
format Online
Article
Text
id pubmed-10040959
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100409592023-03-28 FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis Kim, Jieun Seki, Ekihiro Cell Mol Gastroenterol Hepatol Editorial Elsevier 2023-01-18 /pmc/articles/PMC10040959/ /pubmed/36681094 http://dx.doi.org/10.1016/j.jcmgh.2022.12.018 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Kim, Jieun
Seki, Ekihiro
FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title_full FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title_fullStr FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title_full_unstemmed FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title_short FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
title_sort fap: not just a biomarker but druggable target in liver fibrosis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040959/
https://www.ncbi.nlm.nih.gov/pubmed/36681094
http://dx.doi.org/10.1016/j.jcmgh.2022.12.018
work_keys_str_mv AT kimjieun fapnotjustabiomarkerbutdruggabletargetinliverfibrosis
AT sekiekihiro fapnotjustabiomarkerbutdruggabletargetinliverfibrosis